Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies — Stella

Home/Atrial Fibrillation/Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies

View on ClinicalTrials.gov

Recruiting

Back to Atrial Fibrillation trials

Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies

Trial locations(1 site)

United States

Vanderbilt University Medical Center, Nashville, Tennessee

Key details

Sponsor

Vanderbilt University Medical Center

Enrollment target

~200 participants

Started

December 2023

Primary completion

December 2028

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.